CMA Drops the (Preliminary) Hammer on ILMN-PacBio
Today the United Kingdom's Competition and Merger Authority (CMA) issuedtheir preliminary report on the proposed acquisition of Pacific Biosciences by Illumina. The report has no dry British phrasing: they clearly state that the merger is anticompetitive and that theonly legal remedy is to block the transaction. Interestingly, today was also the scheduled Illumina Q3 earnings call, but the subject wasn't even broached there.Read more »
Source: Omics! Omics! - Category: Bioinformatics Authors: Keith Robison Source Type: blogs